<DOC>
	<DOC>NCT00157963</DOC>
	<brief_summary>An efficacy and safety study of hydrochlorothiazide (+) losartan potassium compared to amlodipine at week 12 in Korean patients with essential hypertension</brief_summary>
	<brief_title>Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)</brief_title>
	<detailed_description />
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients of age 20 70 75 with essential hypertension SiDBP 90 ~ 114mmHg at V1 &amp; V2 Patient has known or suspected secondary hypertension Patient has a history of malignant hypertension (SiSBP &gt; 210mmHg) Individuals has a known sensitivity or intolerance to HCTZ or any AIIAs, or any sulfonamidederived drugs. Patient has shown significant abnormal laboratory evaluations</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>